— Know what they know.
Not Investment Advice

VRCA NASDAQ

Verrica Pharmaceuticals Inc.
1W: +0.2% 1M: -18.7% 3M: -28.6% YTD: -47.2% 1Y: -1.4% 3Y: -88.5% 5Y: -96.2%
$4.38
-0.14 (-2.99%)
 
Weekly Expected Move ±8.2%
$4 $4 $4 $5 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 35 · $75.2M mcap · 9M float · 0.644% daily turnover · Short 60% of daily vol

📊 Key Metrics

TTM
$30M
Revenue
+106.2% YoY
$-31M
Net Income
+35.8% YoY
$-13M
Free Cash Flow
+71.8% YoY
85.0%
Gross Margin
-223.4%
Op. Margin
-224.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE473.3%
ROA-83.0%
ROIC437.4%

Valuation

P/E-2.5
P/B21.7
EV/EBITDA-4.5

Leverage

Debt/Equity0.42
Current Ratio1.45
Interest Cov.-7.4x

Quality Scores

Piotroski F5/9
Altman Z-12.38
Beneish M-3.98

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms